83% of Kids Tolerate More Peanut with VIASKIN Patch in Landmark Study

DBV Technologies reveals new VITESSE Phase 3 data at AAAAI 2026: 83% of kids on VIASKIN Peanut Patch increased safe peanut dose vs 48% on placebo, with excellent safety.

83% of Kids Tolerate More Peanut with VIASKIN Patch in Landmark Study
Photo by Vladislav Nikonov on Unsplash
Already have an account? Sign in.